WebMar 13, 2024 · Metadata Updated: March 13, 2024. Locations of publicly available COVID-19 Therapeutics. Dataset only includes locations for Evusheld (monoclonal antibody), Molnupiravir (antiviral), and Paxlovid (Antiviral). COVID-19 therapeutics require a prescription to obtain. Limitations: public contact information. WebPaxlovid locator site using healthdata.gov data License. Apache-2.0 license 5 stars 1 fork Star Notifications Code; Issues 0; Pull requests 0; Actions; Projects 0; Wiki; Security; Insights; rrelyea/paxlovid. This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository. ...
COVID-19 Test to Treat Locator Mandarin
WebLocator HealthData.gov The National COVID-19 Therapy Locator website contains information on pharmacy locations that have been allocated oral antiviral therapies and Evusheld by HHS/IDPH. The table attached shows the current locations that the government has listed as having (or will soon have) either molnupiravir, Paxlovid, and Evusheld ... WebJan 4, 2024 · PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized by the U.S. FDA for emergency use in both high-risk adults and high-risk … enlarged lump on side of neck
COVID-19 Outpatient Therapy Locator - Illinois
WebMar 30, 2024 · The search for COVID vaccines, tests and treatments could get easier Wednesday with the White House launch of COVID.gov, a website meant to be a one-stop shop for everything from free high quality ... WebThe U.S. Food and Drug Administration (FDA) has approved or issued emergency use authorizations (EUA) for therapeutics for treatment of early mild-to-moderate COVID-19 in high-risk patients: The preferred agent at this time is the oral antiviral nirmatrelvir boosted with ritonavir ( PAXLOVID) begun within 5 days of symptom onset. enlarged lymph node at base of skull